Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mie Shinohara

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2016
[Plasma Biomarkers as Predictive Factors for Advanced Hepatocellular Carcinoma with Sorafenib]Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
The Journal of Biological Chemistry|January 12, 2010
Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1Mie Shinohara, Maria D Ybanez, Sanda Win, et al.
Journal of Medical Ultrasonics (2001)|June 10, 2016
Ultrasonography of intrahepatic bile duct adenoma with renal cell carcinoma: correlation with pathologyManabu Watanabe, Kazue Shiozawa, Takashi Ikehara, et al.
Radiology Research and Practice|August 29, 2014
Evaluation of hemodynamics in focal steatosis and focal spared lesion of the liver using contrast-enhanced ultrasonography with sonazoidKazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 13, 2016
[Evaluation of Sorafenib for Hepatocellular Carcinoma with Low α-Fetoprotein by Arrival Time Parametric Imaging Using Contrast-Enhanced Ultrasonography with Sonazoid]Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
Experimental and Therapeutic Medicine|February 14, 2013
Visualization of segmental arterialization with arrival time parametric imaging using Sonazoid-enhanced ultrasonography in portal vein thrombosis: A case reportNoritaka Wakui, Ryuji Takayama, Yasushi Matsukiyo, et al.
Hepatology International|August 6, 2011
Effects of mutation number in interferon sensitivity determining region on peripheral blood CD4(+) T cell subsets (Th1, Th2) in chronic hepatitis C patients with hepatitis C virus genotype 1b and high viral loadKoji Ishii, Mie Shinohara, Michio Kogame, et al.
Clinical Cancer Drugs|September 6, 2016
The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion ChemotherapyKoichi Momiyama, Hidenari Nagai, Yu Ogino, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2010
Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinomaHidenari Nagai, Teppei Matsui, Masahiro Kanayama, et al.
Clinical & Developmental Immunology|June 6, 2012
Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinomaHidenari Nagai, Takanori Mukozu, Daigo Matsui, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2016
[Plasma Biomarkers as Predictive Factors for Advanced Hepatocellular Carcinoma with Sorafenib]Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
The Journal of Biological Chemistry|January 12, 2010
Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1Mie Shinohara, Maria D Ybanez, Sanda Win, et al.
Journal of Medical Ultrasonics (2001)|June 10, 2016
Ultrasonography of intrahepatic bile duct adenoma with renal cell carcinoma: correlation with pathologyManabu Watanabe, Kazue Shiozawa, Takashi Ikehara, et al.
Radiology Research and Practice|August 29, 2014
Evaluation of hemodynamics in focal steatosis and focal spared lesion of the liver using contrast-enhanced ultrasonography with sonazoidKazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 13, 2016
[Evaluation of Sorafenib for Hepatocellular Carcinoma with Low α-Fetoprotein by Arrival Time Parametric Imaging Using Contrast-Enhanced Ultrasonography with Sonazoid]Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, et al.
Experimental and Therapeutic Medicine|February 14, 2013
Visualization of segmental arterialization with arrival time parametric imaging using Sonazoid-enhanced ultrasonography in portal vein thrombosis: A case reportNoritaka Wakui, Ryuji Takayama, Yasushi Matsukiyo, et al.
Hepatology International|August 6, 2011
Effects of mutation number in interferon sensitivity determining region on peripheral blood CD4(+) T cell subsets (Th1, Th2) in chronic hepatitis C patients with hepatitis C virus genotype 1b and high viral loadKoji Ishii, Mie Shinohara, Michio Kogame, et al.
Clinical Cancer Drugs|September 6, 2016
The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion ChemotherapyKoichi Momiyama, Hidenari Nagai, Yu Ogino, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2010
Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinomaHidenari Nagai, Teppei Matsui, Masahiro Kanayama, et al.
Clinical & Developmental Immunology|June 6, 2012
Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinomaHidenari Nagai, Takanori Mukozu, Daigo Matsui, et al.
Pageof 3